10/23/2026
Science Friday question of the day: Why’s a norovirus vax taking so long?
Last January, we blogged – with great hope – about the much-anticipated release of a norovirus vaccine.
Regrettably, a vaccine to prevent the yucky GI virus isn’t quite ready. Even the brightest of white-coated researchers have struggled with scientific challenges behind the vaccine’s development. Here’s why:
First, the norovirus stubbornly refused to be grown inside laboratories until about a decade ago. That means our understanding of the virus—and our ability to create an effective vaccine—is approximately in its toddlerhood.
Second, the norovirus keeps changing, not unlike how influenza viruses behave. Every few years, its surface protein changes; this means antibodies that worked against last season’s strain may be less effective against the next one.
Third, lasting immunity is tough to achieve. Even protection from a natural infection (sickness) lasts only four and nine years. If nature’s own immune response is inconsistent and short-lived, a man-made vaccine needs to do better, and that’s a big ask.
While we’re stuck with “GI ick” for now, promising results are coming. Both drug manufacturers and academic labs are on the chase, pursuing mid- and late-stage clinical trials.
